Kolexia
Morice Marie-Claude Cardiologie
Morice Marie-Claude
Cardiologie
Hôpital privé Jacques Cartier
Massy, France
550 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie des artères coronaires Infarctus du myocarde Maladie coronarienne Ischémie myocardique Hémorragie Thrombose Infarctus Sténose aortique Sténose coronarienne

Collaborateurs

Voir plus
Lefevre Thierry
Lefevre Thierry
Hôpital Claude Galien, Quincy-sous-Sénart, France
Garot Philippe
Garot Philippe
Hôpital Claude Galien, Quincy-sous-Sénart, France
Hovasse Thomas
Hovasse Thomas
Hopital Prive D Antony, Antony, France
Chevalier Bernard
Chevalier Bernard
Cabinet libéral, Massy, France

Industries

Voir plus
Medtronic
4 collaboration(s)
Dernière en 2021
Biosensors Europe SA
1 collaboration(s)
Dernière en 2020
ASSOCIATION POUR LE DEVELOPPEMENT DE LA COMMUNICATION EN CARDIOLOGIE INTERVENTIONNELLE (ADCCI)
1 collaboration(s)
Dernière en 2022
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
LANDMARK: A Prospective, Multinational, Multicentre, Open-label, Randomised, Non-inferiority Trial to Compare Safety and Effectiveness of Meril's Myval Transcatheter Heart Valve (THV) Series vs. Contemporary Valves (Edwards's Sapien THV Series and Medtronic's Evolut THV Series) in Patients With Severe Symptomatic Native Aortic Valve Stenosis
Essai Clinique (Meril Life Sciences Pvt. Ltd.)   14 mars 2024
Geographical variations in the effectiveness and safety of abbreviated or standard antiplatelet therapy after PCI in patients at high bleeding risk.
The Canadian journal of cardiology   01 février 2024
Cost-effectiveness of stepwise provisional versus systematic dual stenting strategies in patients with distal bifurcation left main stem lesions: economic analysis of the EBC MAIN trial.
Open heart   19 janvier 2024
SENIOR: Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization.
Essai Clinique (Ceric Sàrl)   11 janvier 2024
Prognostic impact of pre-frailty and frailty in women undergoing TAVR: Insights from the WIN-TAVI Registry.
The Canadian journal of cardiology   01 novembre 2023
First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT.
EClinicalMedicine   24 octobre 2023
The SELUTION DeNovo Study: SELUTION DeNovo - A Prospective Randomized, Multi-center, International, Single-blind, Clinical Trial Compared the Selution DEB Strategy Versus DES Strategy.
Essai Clinique (M.A. Med Alliance S.A.)   18 octobre 2023
BIOADAPTOR RCT: Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Essai Clinique (Elixir Medical Corporation)   05 septembre 2023
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology   23 août 2023
Impact of Left Ventricular Ejection Fraction on 10-Year Mortality After Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Is CABG Safer Than PCI in All Patients With Reduced Ejection Fraction?
Cardiovascular revascularization medicine : including molecular interventions   01 août 2023